Cell therapy for stress urinary incontinence: Present‐day frontiers. (2nd August 2017)

• Record Type: Journal Article
• Authors: Vinarov, Andrey; Atala, Anthony; Yoo, James; Slusarenco, Roman; Zhumataev, Marat; Zhito, Alexey; Butnaru, Denis
• Is Part Of: Journal of tissue engineering and regenerative medicine. Volume 12:Number 2(2018)
• Page Start: e1108
• Page End: e1121
• Publication Date: 2017-08-02
• Subjects: cell‐based therapy -- cell injection techniques -- stem cells -- stress urinary incontinence -- tissue engineering -- urethral sphincter; Tissue engineering -- Periodicals; Regeneration (Biology) -- Periodicals; 610.28
• DOI: 10.1002/term.2444
• Languages: English
• ISSNs: 1932-6254

Abstract

Abstract: Stress urinary incontinence (SUI) significantly diminishes the quality of patients' lives. Currently available surgical and nonsurgical therapies remain far from ideal. At present, advances in cellular technologies have stirred growing interest in the use of autologous cell treatments aimed to regain urinary control. The objective was to conduct a review of the literature and analyse preclinical and clinical studies dedicated to various cell therapies for SUI, assessing their effectiveness, safety, and future prospects. A systematic literature search in PubMed was conducted using the following key terms: "stem, " "cell, " "stress, " "urinary, " and "incontinence." A total of 32 preclinical studies and 15 clinical studies published between 1946 and December 2014 were included in the review. Most preclinical trials have used muscle‐derived stem cells and adipose‐derived stem cells. However, at present, the application of other types of cells, such as human amniotic fluid stem muscle‐derived progenitor cells and bone marrow mesenchymal stromal cells, is becoming more extensive. While the evidence shows that these therapies are effective and safe, further work is required to standardize surgical techniques, as well as to identify indications for their use, doses and number of doses. Future research will have to focus on clinical applications of cell therapies; namely, it will have to determine indications for their use, doses of cells, optimal surgical techniques and methods, attractive cell sources, as well as to develop clinically relevant animal models and make inroads into understanding the mechanisms of SUI improvement by cell therapies.